Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human RAMP1 ELISA Kit (AC3889)
Cat.#: ASET-2478
Specifications
Description Human RAMP1 ELISA Kit allows for the in vitro quantitative determination of human RAMP1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2128 Human Chromogranin A ELISA Kit (AC3539) Quantitative inquiry ASET-2378 Human Adiponectin ELISA Kit (AC3789) Quantitative inquiry ASET-1177 Human PCDH20 ELISA Kit (AC2588) Quantitative inquiry ASET-1955 Rat Cannabinoid Receptor I ELISA Kit (AC3366) Quantitative inquiry ASET-1696 Mouse Angiogenin ELISA Kit (AC3107) Quantitative inquiry ASET-1288 Human Somatostatin Receptor 2 ELISA Kit (AC2699) Quantitative inquiry ASET-2093 Human HEXA ELISA Kit (AC3504) Quantitative inquiry ASET-2200 Mouse PGRPS ELISA Kit (AC3611) Quantitative inquiry ASET-2505 Rat Luteinizing Hormone ELISA Kit (AC3916) Quantitative inquiry ASET-2216 Human Insulin Receptor ELISA Kit (AC3627) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket